PediaLink & EQIPP Courses /

Managing Pediatric Acute and Chronic Pain and Substance Use Disorders 2026

Name: Managing Pediatric Acute and Chronic Pain and Substance Use Disorders 2026
Brand: American Academy of Pediatrics
SKU: 3220CA11-B0D2-4A2B-B17C-A4E7E9B154F1
Availability: InStock

MOC

Available: 07/31/2026-07/30/2029

Format

Price: $275.00

Member Price: $205.00

Description and Learning Objectives

Description

This course will meet the new government-mandated requirement for all DEA-registered practitioners to complete eight hours of training on the treatment and management of patients with opioid or other substance use disorders prior to applying for or renewing their license.

Pain in pediatric patients is common, under-recognized, and undertreated. Unrelieved acute, chronic, and needle pain in childhood directly results in poorer clinical outcomes, including increased morbidity, degree of anxiety, needle-phobia, health care avoidance, and chronic pain, which may contribute to substance use disorders.

Focused on pediatrics, this online course addresses pain management and opioid state medical board CME requirements. It also meets the new DEA requirements, found in the Medication Access and Training Expansion (MATE) Act, to complete eight hours of training on the treatment and management of patients with opioid or other substance use disorders prior to applying for or renewing their license.

Developed for general pediatricians, pediatric subspecialists, other pediatric clinicians, and allied health professionals, this evidence-based course includes clinical content and question-and-answer sessions from the AAP’s 2023 Acute and Chronic Pain course.

By participating in this CME activity, you will be able to:

Diagnose, manage, and treat children from infancy to adolescence for acute and chronic pain.
Identify and implement strategies to address substance use disorders and safely prescribe analgesics in pediatric practice.
Identify the influence of bias and adverse childhood events on pain treatment.

Course Details

Start Date: July 31, 2026
Online Access Expires: July 30, 2029
Credit Expires: July 30, 2029
Course ID: 62736

Faculty

David K. Becker, MD, LMFT, FAAP
Cristina Benki, PhD
William E. Bernal, MD, MPH
David A. Burns, MD
Deepa Camenga, MD, MHS, FAAP
Stefan J. Friedrichsdorf, MD, FAAP
Lucien Gonzalez, MD, MS, FAAP
Stephen R. Hays, MD, FAAP
Claudia R. Morris, MD, FAAP
Tim F. Oberlander, MD
Stacy Peterson, MD, FAAP
Michael Sangster, BScPT, DPT
Neil L. Schechter, MD, FAAP
Scott A. Schwantes, MD, FAAHPM, FAAP
Christine B. Sieberg, PhD, EdM, MA
Karen I. Sun, MD
Marsha Treadwell, PhD
Gary A. Walco, PhD, ABPP

Registration Fees

Pediatrician Member Fee: $205

Trainee Member Fee: $205

Medical Student Member Fee: $170

Resident Member Fee: $130

Non-Member Fee: $275

Credit Information

AMA PRA Category 1 Credit™
Enduring Materials

10.00
AAP Credit Only
AAP Credit

10.00
NAPNAP
NAPNAP Contact Hours

10.00
NAPNAP Pharmacology Rx

0.50
NAPNAP Controlled Substances

1.50
MOC
MOC Part 2

10.00
AAPA
AAPA Credit Hours

10.00

Credit Statements

Physician - Managing Pediatric Acute and Chronic Pain and Substance Use Disorders 2026

The American Academy of Pediatrics (AAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The AAP designates this enduring material for a maximum of 10.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is acceptable for a maximum of 10.00 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the AAP.

This activity is approved for 10.00 points of MOC Part 2 credit by the American Board of Pediatrics through the AAP MOC Portfolio Program. All approved activities must be completed by the MOC Credit Approval End Date. All deadlines and MOC point values should be confirmed by checking the ABP Activity Catalog within each physician’s ABP Portfolio. Consult your ABP portfolio at www.abp.org for details about your specific certification requirements. For questions about how to access this activity, contact [email protected].

Allied Health Professional - Managing Pediatric Acute and Chronic Pain and Substance Use Disorders 2026

The American Academy of Pediatrics (AAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

PAs may claim a maximum of 10.00 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

This program is accredited for 10.00 NAPNAP CE contact hours of which 0.50 contain pharmacology (Rx) content, (0.00 related to psychopharmacology) (1.50 related to controlled substances), per the National Association of Pediatric Nurse Practitioners (NAPNAP) Continuing Education Guidelines. The AAP is designated as Agency #A17. Upon completion of the program, each participant desiring NAPNAP contact hours must send a completed certificate of attendance to [email protected]. Payment of $15 for NAPNAP members and nonmembers is required via credit card for all NAPNAP contact hour requests. Keep this certificate for your records for six (6) years. Requests for duplicate certificates should be made to the AAP.

Technical Requirements

Recommended Browsers: